433: Mitochondria-Targeted Therapy Against Acute Organophosphate Poisoning

Joanna I. Janowska(Children's Hospital of Philadelphia), Todd J. Kilbaugh(Children's Hospital of Philadelphia), Piotr Janowski, David H. Jang(Children's Hospital of Philadelphia), Sarah Piel(Düsseldorf University Hospital), Carly L. Clayman(Children's Hospital of Philadelphia), Claire Kim(Children's Hospital of Philadelphia), J. Laurenson Ward(Children's Hospital of Philadelphia), Johannes Ehinger(Lund University), Michael Karlsson(Lund University), Ryan W. Morgan(University of Pennsylvania)
Critical Care Medicine
December 11, 2020
10.1097/01.ccm.0000727620.81448.36
Cited by 0

Related Papers

Update on Immunologic Therapy With Anti–CTLA-4 Antibodies in Melanoma: Identification of Clinical and Biological Response Patterns, Immune-Related Adverse Events, and Their Management
|Seminars in Oncology|2010|170
Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency
|Nature Communications|2016|153
Effect of Physiologic Point-of-Care Cardiopulmonary Resuscitation Training on Survival With Favorable Neurologic Outcome in Cardiac Arrest in Pediatric ICUs
|JAMA|2022|77
Ventilation Rates and Pediatric In-Hospital Cardiac Arrest Survival Outcomes*
|Critical Care Medicine|2019|76
Metformin induces lactate production in peripheral blood mononuclear cells and platelets through specific mitochondrial complex I inhibition
|Acta Physiologica|2014|70